Ayalur Raghu Subbalakshmi, Aditya Agrawal, Shibjyoti Debnath, Kishore Hari, Sarthak Sahoo, Jason A Somarelli, Mohit Kumar Jolly
{"title":"Systems-level analysis identifies IRF6 as an inhibitor of epithelial-mesenchymal transition.","authors":"Ayalur Raghu Subbalakshmi, Aditya Agrawal, Shibjyoti Debnath, Kishore Hari, Sarthak Sahoo, Jason A Somarelli, Mohit Kumar Jolly","doi":"10.1186/s13036-026-00706-0","DOIUrl":"10.1186/s13036-026-00706-0","url":null,"abstract":"<p><strong>Background: </strong>Epithelial-mesenchymal transition (EMT) and its reverse process mesenchymal-epithelial transition (MET) are crucial during metastasis and therapy resistance. While the dynamics and master regulators of EMT are well-studied, the transcription factors that can prevent EMT or promote MET are relatively less understood.</p><p><strong>Results: </strong>Here, by integrating bulk and spatial transcriptomic data analysis from cell lines and patient samples with mechanism-based dynamical modelling we identify IRF6 as a factor that strongly associates with an epithelial phenotype and is often inhibited during EMT. In vitro experiments in multiple cancer cell lines demonstrate the progression to a mesenchymal phenotype upon IRF6 knockdown, suggesting a role as an inhibitor of EMT. Finally, we observe that IRF6 expression levels correlate with worse patient survival in a subset of solid tumour types.</p><p><strong>Conclusion: </strong>Our integrated computational-experimental, systems-level analysis suggests that IRF6 is frequently downregulated during EMT and can also prevent the progression towards a complete EMT, underscoring its role as an MET stabilizing factor.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13491704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148251723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unravelling the metabolism of itaconate and related branched C5-dicarboxylates for CO<sub>2</sub>-based production in Cupriavidus necator H16.","authors":"Erik K R Hanko, Naglis Malys","doi":"10.1186/s13036-026-00711-3","DOIUrl":"10.1186/s13036-026-00711-3","url":null,"abstract":"<p><p>Branched C5-dicarboxylates (C5-DCAs), such as itaconate, are high-value platform chemicals with diverse applications in the synthesis of bio-based polymers. In addition to their industrial relevance, itaconate has attracted attention as a key immunomodulatory metabolite. In this study, we demonstrated that Cupriavidus necator can grow on itaconate as its sole carbon source and identified key genes involved in its degradation through targeted deletions. These include multiple functional homologs of itaconate CoA-transferase, itaconyl-CoA hydratase, and (S)-citramalyl-CoA lyase, which collectively mediate itaconate catabolism. We also identified ItcR1, a LysR-type transcriptional regulator, as a key mediator of itaconate-responsive gene expression. Transcriptomic analysis revealed broader transcriptional responses to itaconate, methylsuccinate, and mesaconate, suggesting an expanded role of C5-DCA metabolism. Finally, by expressing a heterologous cis-aconitate decarboxylase, we achieved the autotrophic production of a C5-DCA mixture of methylsuccinate, citramalate, mesaconate, and itaconate from CO<sub>2</sub> and hydrogen. These findings provide new insight into branched C5-DCA metabolism in C. necator and advance its development as a chassis for the sustainable production of these industrially relevant compounds from inorganic feedstocks.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13491972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148251695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"MelC tyrosinase-dependent enzymatic synthesis of functional melanins from phenolic monomers.","authors":"Nimya Krishnan, Koijam Monica Devi, Chan-Seo Yeo, Kwon-Young Choi","doi":"10.1186/s13036-026-00710-4","DOIUrl":"10.1186/s13036-026-00710-4","url":null,"abstract":"<p><p>Sustainable microbial bioproduction offers a promising route to synthesize high-value melanin biopolymers, yet its scalability is fundamentally limited by the high cost of the L-tyrosine precursor. Here, we aimed to overcome this economic barrier by a highly efficient, engineered microbial platform that utilizes recombinant Escherichia coli expressing MelC tyrosinase to convert diverse, cost-effective noncanonical phenolic monomers into customizable melanin-like biopolymers. Among 13 screened substrates, p-Cresol (PC) and 4-hydroxyphenylacetic acid were the most efficient precursors, yielding 2.40 g/L and 3.92 g/L, respectively. Structural analyses (Ultraviolet-visible spectroscopy, Fourier-transform infrared, Solid-state NMR, MALDI-TOF MS, scanning electron microscopy, Energy-dispersive X-ray spectroscopy, X-ray diffraction, EPR) revealed that these biopolymers possess a native eumelanin-like amorphous architecture while exhibiting partial Dimethyl sulfoxide solubility for improved processability. The synthesized eumelanin-like pigments exhibited high thermal stability (retaining > 37% mass at 800 °C) and strong antioxidant activity, with PC-melanin outperforming conventional eumelanin by twenty-fold. Most importantly, these novel substrates are effluents of industrial and agriculture waste. Thus, this strategy frames a new method for bioremediation. These customizable eumelanin-like pigments hold strong potential for demanding industrial applications, including high-temperature coatings and advanced electronics.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13480188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148217860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anna Mestre Borras, Hanna Mehari, Athanasios Bitzios, Ivan Zelepukin, Moeen Ud-Din, Tianqi Xu, Sihan Li, Anna Orlova, Vladimir Tolmachev, Stefan Ståhl, Anzhelika Vorobyeva, John Löfblom
{"title":"Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.","authors":"Anna Mestre Borras, Hanna Mehari, Athanasios Bitzios, Ivan Zelepukin, Moeen Ud-Din, Tianqi Xu, Sihan Li, Anna Orlova, Vladimir Tolmachev, Stefan Ståhl, Anzhelika Vorobyeva, John Löfblom","doi":"10.1186/s13036-026-00705-1","DOIUrl":"10.1186/s13036-026-00705-1","url":null,"abstract":"<p><p>The application of monoclonal antibodies as targeted drugs has revolutionized cancer therapy, yet their efficacy is sometimes limited by toxicities arising from target expression in healthy tissues. Various strategies have emerged to overcome these issues, including the design of antibody-based prodrugs. Here, we report the generation of affibody-based masking domains designed to specifically bind and mask the paratope of the anti-epidermal growth factor receptor (EGFR) antibody, cetuximab. Bacterial display of affibody library and cell sorting were employed to isolate suitable candidates. Both experimental and computational analyses confirmed that several of these selected affibodies effectively blocked cetuximab from binding EGFR. A cetuximab prodrug was created by fusing the most promising masking candidate to the antibody heavy chains. The prodrug demonstrated over 400-fold difference in growth inhibition effect between its masked and unmasked states in vitro. A biodistribution study comparing cetuximab and its prodrug demonstrated the feasibility of conditional activation of the cetuximab prodrug in a xenograft mouse model. This study is the first to describe the use of an affibody masking domain to create an antibody-based prodrug, demonstrating significant potential for further development of safer and more efficacious cancer therapies.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13248396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148205038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"UniSePT: an engineered broadly applicable Unique Secretory signal PepTide for high-yield biotherapeutic production in mammalian cell-based expression systems.","authors":"Goutam Ulgekar, Satarupa Dutta, Ealisha Jain, Meenakshi Mansukhani, Harshada Thawari, Subeer S Majumdar, Nirmalya Ganguli","doi":"10.1186/s13036-026-00704-2","DOIUrl":"10.1186/s13036-026-00704-2","url":null,"abstract":"<p><strong>Background: </strong>The yield of therapeutic proteins in mammalian cell-based production systems is often limited by inefficient secretion and reduced bioactivity caused by incompatible secretory signal peptides (SPs). Therefore, a broadly applicable signal peptide that can be fused to different proteins of interest to enhance their secretion and overall production is needed.</p><p><strong>Results: </strong>To address this challenge, we engineered a robust, broadly applicable Unique Secretory signal PepTide (UniSePT) by combining SP sequences from β-casein (CSN2) and β-lactoglobulin (BLG) proteins of Indian river buffalo. UniSePT demonstrated higher secretion efficiency than commonly used SPs, such as human serum albumin and preproinsulin SP. Importantly, this improved secretion does not compromise the bioactivity of the therapeutic proteins produced. Additionally, UniSePT showed minimal cleavage variability, supporting its compatibility with various therapeutic proteins.</p><p><strong>Conclusion: </strong>The newly developed UniSePT enhances the titer and bioactivity of therapeutic proteins in mammalian expression systems. Its broad applicability and improved secretion efficiency make it a promising tool for industrial-scale production, potentially reducing the cost of therapeutic protein production.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13471251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148205060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Qi Chen, Yanyun Ruan, Shuanshuan Liu, Hozeifa M Hassan, Shaoyin Bao, Weiliang Liu, Jianguo Sun, Hongsheng Lu
{"title":"Clitocine suppresses TNBC progression by boosting CCRL2 to block survival signals and neutrophil-driven inflammation.","authors":"Qi Chen, Yanyun Ruan, Shuanshuan Liu, Hozeifa M Hassan, Shaoyin Bao, Weiliang Liu, Jianguo Sun, Hongsheng Lu","doi":"10.1186/s13036-026-00707-z","DOIUrl":"10.1186/s13036-026-00707-z","url":null,"abstract":"<p><strong>Background: </strong>This study investigates the anti-tumor mechanisms of clitocine, a natural compound, in triple-negative breast cancer (TNBC), with a focus on its role in modulating the immune microenvironment via C-C motif chemokine receptor like 2 (CCRL2). The anti-cancer effects of clitocine were assessed in vitro using TNBC cell lines (MDA-MB-231 and MDA-MB-468) through functional assays, flow cytometry, and immunoblotting. RNA sequencing was performed to identified clitocine-induced transcriptional changes. The subcutaneous 4T1 xenograft models in BALB/c mice were used for in vivo validation. Additionally, mass cytometry (CyTOF) profiled tumor immune infiltration in tumor tissues, and the role of CCRL2 in modulating the tumor immune microenvironment and inflammatory pathways was investigated through database mining (TCGA) and gain/loss-of-function experiments.</p><p><strong>Results: </strong>Clitocine potently inhibits TNBC cell proliferation, metastasis, and epithelial-mesenchymal transition (EMT), while inducing mitochondrial apoptosis. It alters cancer-related gene expression (upregulating CCRL2), suppresses PI3K-AKT, NFκB, and ERK pathways, and exhibits potent antitumor activity in vivo without systemic toxicity. Mechanistically, clitocine remodels the tumor immune microenvironment by reducing neutrophil infiltration and suppressing neutrophil extracellular traps (NETs) formation, effects mediated through the CCRL2/chemerin axis. Furthermore, CCRL2 is identified as a tumor suppressor, with low expression in TNBC patients correlating with poor survival. Credibly, CCRL2 knockdown in vitro and in vivo significantly abrogates the anti-tumor and immunomodulatory effects of clitocine.</p><p><strong>Conclusion: </strong>Our findings demonstrate that clitocine exerts potent anti-TNBC effects by upregulating CCRL2 expression, thereby activating the clitocine/CCRL2/chemerin axis. This axis disrupts critical oncogenic signaling pathways and reprograms the immunosuppressive tumor microenvironment.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13471378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148205010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ilaria De Martino, Luigi Russo, Matteo Marchetti, Velia Siciliano
{"title":"Engineering a PD-L1-sensing synthetic receptor for programmable macrophage response.","authors":"Ilaria De Martino, Luigi Russo, Matteo Marchetti, Velia Siciliano","doi":"10.1186/s13036-026-00708-y","DOIUrl":"10.1186/s13036-026-00708-y","url":null,"abstract":"<p><p>Cellular decision-making relies on the integration of multiple extracellular cues into coordinated functional responses. Synthetic biology provides tools to rewire this process by engineering receptors that convert defined inputs into programmable outputs. Here, we describe a synthetic receptor-based architecture that enables monocytic-like cells to sense an immune-regulatory ligand and conditionally activate a phagocytic program. We engineered a synthetic Notch-based receptor (SNIPR) that detects programmed death-ligand 1 (PD-L1), a broadly expressed immune-regulatory ligand. Upon PD-L1 engagement, the circuit triggers programmable outputs, including expression of a fluorescent reporter or CV1-Fc, as model effector that interferes with CD47-mediated inhibition of phagocytosis. We show that circuit activation scales with PD-L1 levels, partially attenuates PD-1/PD-L1 signaling, and that conditional CV1-Fc expression enhances engulfment of SKOV-3 ovarian cancer cells by THP-1-derived macrophages in vitro. Collectively, this work reframes PD-L1 from an end-point therapeutic target to a programmable input signal for synthetic circuit activation and establishes a modular framework for ligand-responsive control of engineered macrophage behaviour.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13459757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148194711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Niloofar Bajool, Mehdi Abdolazimi, Mohsen Razzaznian, Zeinab Zakerian, Sharif Moradi
{"title":"Stem cell research and regenerative medicine: meeting report from the Royan International Stem Cell Congress 2025.","authors":"Niloofar Bajool, Mehdi Abdolazimi, Mohsen Razzaznian, Zeinab Zakerian, Sharif Moradi","doi":"10.1186/s13036-026-00702-4","DOIUrl":"10.1186/s13036-026-00702-4","url":null,"abstract":"<p><p>The 21st Royan International Stem Cell Congress (3-5 September 2025, Tehran, Iran) convened the global stem cell community to assess the accelerating translation of regenerative medicine from bench to bedside. Over three days, 10 thematic sessions, spanning pluripotency, cancer, organoid technology, molecular biomedicine, artificial intelligence (AI), bioengineering, and clinical translation, provided a comprehensive overview of a field undergoing increasing integration. Key presentations reported recent progress in several areas: the generation of primate and human embryo models for developmental study; new strategies in cross-species reprogramming and exosome-based therapeutics; and the application of AI for patient stratification, drug repurposing, and metabolic modeling. Concurrently, sessions on bioengineering showcased developments in next-generation biomaterials, non-viral gene delivery systems, and scalable microfluidic platforms aimed at enhancing therapeutic safety and manufacturability. The congress also featured critical discussions on regulatory frameworks, bioentrepreneurship, and the ecosystem required to support clinical adoption. Collectively, the meeting underscored a continuing shift toward a multidisciplinary paradigm in which foundational biology, emerging technology, and pragmatic translation converge to advance the development of safe, effective, and accessible stem cell-based therapies worldwide.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":"20 1","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13238096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148163374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Microengineered bone models: advances and applications of bone-on-a-chip technology.","authors":"Hossein Rayat Pisheh, Ahmad Vaez","doi":"10.1186/s13036-026-00703-3","DOIUrl":"10.1186/s13036-026-00703-3","url":null,"abstract":"<p><p>Bone-on-a-Chip (BoC) platforms are emerging microphysiological systems designed to recapitulate the complex cellular, structural, and mechanical microenvironments of human bone. These microfluidic-based models provide enhanced physiological relevance for studying bone remodeling dynamics, disease progression, and drug responses compared to traditional 2D cultures. This review discusses the anatomical and pathophysiological features of bone that must be replicated in vitro, highlighting recent advances in BoC platforms and their applications in regenerative medicine, drug discovery, and personalized therapy. However, despite their potential, current BoC technologies still face significant challenges, including the simplified representation of the extracellular matrix, incomplete recapitulation of the dense osteocyte network, and partial reproduction of native biomechanical stimuli. Furthermore, integrating vascularization, immune components, and ensuring scalability remain critical hurdles. Future directions focus on developing multi-tissue interfaces, advanced biomaterials, real-time sensing technologies, and AI-assisted data analysis. While still evolving, BoC technology serves as a promising tool for bridging the gap between in vitro models and clinical applications in translational bone research.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13445809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148149946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Taeho Kim, Dongseong Seo, Jonghyun Park, Dongmin Yu, Chanju Choi, Sohyeon Yu, Jeongmin Shin, Simseok A Yuk, Daekyung Sung, Hyungjun Kim
{"title":"Tunable PEGylation platform for efficient siRNA delivery using mesoporous silica nanoparticles.","authors":"Taeho Kim, Dongseong Seo, Jonghyun Park, Dongmin Yu, Chanju Choi, Sohyeon Yu, Jeongmin Shin, Simseok A Yuk, Daekyung Sung, Hyungjun Kim","doi":"10.1186/s13036-026-00701-5","DOIUrl":"10.1186/s13036-026-00701-5","url":null,"abstract":"<p><p>Poly(ethylene glycol) (PEG) coatings are widely used to improve nanoparticle stability and biocompatibility, yet conventional PEGylation methods rely on multi-step conjugation that limits reproducibility and restricts control over charge-shielding balance critical for siRNA delivery. Here, we present a composition-tunable PEGylation strategy based on poly(2-(dimethylamino)ethyl methacrylate-co-poly(ethylene glycol) methacrylate) (poly(DMAEMA-co-PEGMA), hereafter referred to as AP) copolymers for the efficient delivery of PD-L1 siRNA using mesoporous silica nanoparticles (MSNs). Copolymers with varying DMAEMA: PEGMA ratios (2:1, 1:1, 0.5:1) and PEG chain lengths (Mn 450 or 950 Da) were synthesized via one-step free-radical polymerization, enabling precise tuning of surface charge and steric stabilization. The optimized MSN/copolymer complexes exhibited enhanced siRNA loading, colloidal stability, and serum resistance while maintaining favorable cytocompatibility. Cellular studies demonstrated improved uptake and significant PD-L1 gene silencing. This work establishes a composition-tunable and scalable PEGylation platform that overcomes the limitations of conventional surface modification and provides a potential strategy for siRNA-based applications.</p>","PeriodicalId":15053,"journal":{"name":"Journal of Biological Engineering","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2026-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13410597/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148054703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}